Organization | Kaohsiung Medical University

Kaohsiung Medical University Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Founded: Kaohsiung Taiwan (1954)

Organization Overview

First Clinical Trial

1994

NCT00201344

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Chung-Ho Memorial Hospital, Kaohsiung Medical University | Department of anesthesiology,Kaohsiung Municipal Ta-Tung Hospital , Kaohsiung City 801，Taiwan (R.O.C.) | Department of Gastroenterology, Kaohsoung Veterans General Hospital | Department of General Surgery, Kaohsiung Veterans General Hospital | Department of Internal Medicine, Kaohsiung Medical University Hospital | Department of Pediatrics, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan. | Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University | Graduate School of Medicine, Kaohsiung Medical University | Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan | Hepatobiliary Division, Kaohsiung Medical University Hospital | Jaw-Yuan Wang, MD, PhD | Kaohsiung Chang Gung Memorial Hospital,Taiwan | Kaohsiung Kai-Suan Psychiatric Hospital | Kaohsiung Medical University | Kaohsiung Medical University Chung-Ho Memorial Hospital | Kaohsiung Medical University Department of Physical Therapy Associate Professor | Kaohsiung Medical University Department of Sports Medicine professor | Kaohsiung Medical University Hospital, Internal Medicine | Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung City, Taiwan (R.O.C.) | Kaohsiung Medical University Hospital - Taiwan | Kaohsiung Medical University, Orthopedics Department | Kaohsiung Medical Univestity | Kaohsiung Municipal Hsiao-Kang Hospital | Kaohsiung Municipal Kai-Syuan Psychiatric Hospital, Kaohsiung City, Taiwan | Kaohsiung Municipal Ta-Tung Hospital | Kaohsiung Municipal United Hospital | Kaohsiung Veterans General Hospital | Kaohsiung Veterans General Hospital. | Kaohsiung Veterans General Hospital, Department of Anesthesiology | Kaohsiung Veterans General Hospital (KVGH) | Kaohsiung Veterans General Hospital (KVGH), Taiwan | Kaohsiung Veterans General Hospital, Taiwan | Kaohsoung Veterans General Hospital | Kaoshiung Medical University | Kaoshiung Medical University Hospital, Kaoshiung, Taiwan | Kaoshiung Medical University Hospital, Taiwan | Kaoshiung, Taiwan | Ping-I (William) Hsu, M.D. | Veterans General Hospital, Kaohsiung, Taiwan | Vice President, Kaohsiung Medical University

Active Ingredients

Drugs in Phase 4 Trials (42)

adefovir dipivoxil (hepsera) (2 trials)

agomelatine (Valdoxan) (1 trial)

alendronic acid (fosamax) (1 trial)

amisulpride (BARHEMSYS) (1 trial)

amoxicillin (8 trials)

autologous microbiome (1 trial)

Bismuth Subcitrate Potassium (Pylera) (2 trials)

cilostazol (pletal) (1 trial)

clarithromycin (biaxin) (16 trials)

dexlansoprazole (dexilant) (3 trials)

esomeprazole (nexium) (8 trials)

fentanyl (Innovar) (2 trials)

fluoxetine (prozac) (1 trial)

hyaluronic acid (6 trials)

hydralazine (apresoline) (1 trial)

interferon alpha-2a (roferon-a) (1 trial)

interferon alpha-2b (Intron-A) (11 trials)

lactobacillus plantarum (1 trial)

lamivudine (epivir) (3 trials)

ledipasvir (Harvoni) (1 trial)

lidocaine (xylocaine) (3 trials)

metronidazole (flagyl) (14 trials)

moxifloxacin (avelox) (1 trial)

nalbuphine (nubain) (3 trials)

olanzapine (zyprexa) (1 trial)

omeprazole (prilosec) (2 trials)

onabotulinumtoxinA (Botox) (1 trial)

platelet-rich plasma (7 trials)

procaine benzylpenicillin (novocaine) (11 trials)

propofol (diprivan) (6 trials)

rabeprazole (pariet) (8 trials)

ribavirin (virazole) (14 trials)

risperidone (risperdal) (1 trial)

sevoflurane (ultane) (4 trials)

silymarin (1 trial)

sofosbuvir (sovaldi) (2 trials)

sugammadex (bridion) (2 trials)

sulbactam (unasyn) (1 trial)

tenofovir (viread) (1 trial)

tenofovir alafenamide (genvoya) (3 trials)

triamcinolone (kenalog) (1 trial)

vonoprazan (Voquezna) (1 trial)

Drugs in Phase 3 Trials (26)

aflibercept (zaltrap) (1 trial)

astragalus membranaceus (4 trials)

asunaprevir (1 trial)

bismuth (5 trials)

boceprevir (victrelis) (1 trial)

cisplatin (platinol) (2 trials)

daclatasvir (daklinza) (1 trial)

dapagliflozin (farxiga) (1 trial)

dexmedetomidine (precedex) (3 trials)

elbasvir (1 trial)

epirubicin (ellence) (2 trials)

fluorouracil (efudex) (6 trials)

grazoprevir (zepatier) (1 trial)

hydroxyurea (hydrea) (1 trial)

leucovorin (8 trials)

mitomycin (mutamycin) (1 trial)

naproxen (naprosyn) (1 trial)

neurotropin (1 trial)

pegylated-interferon (1 trial)

rifapentine (priftin) (1 trial)

sitagliptin (januvia) (1 trial)

sodium chloride (2 trials)

tamoxifen (nolvadex) (2 trials)

tetracycline (tetrex) (4 trials)

velpatasvir (Epclusa) (1 trial)

warfarin (coumadin) (1 trial)

Drugs in Phase 2 Trials (36)

afatinib (gilotrif) (1 trial)

bi 754091 (1 trial)

burixafor (1 trial)

cabozantinib (cometriq) (1 trial)

capecitabine (xeloda) (1 trial)

carboplatin (paraplatin) (1 trial)

cetuximab (erbitux) (1 trial)

colchicine (colbenemid) (2 trials)

crizotinib (xalkori) (1 trial)

cstc1 (1 trial)

cyclophosphamide (cytoxan) (1 trial)

docetaxel (taxotere) (1 trial)

doxorubicin (Doxil) (1 trial)

gemcitabine (gemzar) (4 trials)

gimeracil (4 trials)

irinotecan (Camptosar) (3 trials)

jbm-tc4 (1 trial)

lanreotide (somatuline depot) (1 trial)

lansoprazole (prevacid) (1 trial)

lenvatinib (lenvima) (1 trial)

letrozole (femara) (1 trial)

mycophenolate (CellCept) (1 trial)

nemonoxacin (1 trial)

oteracil (4 trials)

oxaliplatin (eloxatin) (4 trials)

paclitaxel (taxol) (2 trials)

pep503 (1 trial)

phn121 (1 trial)

pioglitazone (actos) (1 trial)

polyethylene glycol (1 trial)

regorafenib (stivarga) (2 trials)

ropivacaine (naropin) (2 trials)

tegafur (5 trials)

ub-421 (4 trials)

Drugs in Other Trials (29)

allogeneic bone marrow (1 trial)

amniotic suspension (1 trial)

astaxanthin (1 trial)

bevacizumab (avastin) (1 trial)

bictegravir (Biktarvy) (1 trial)

danggui buxue tang (1 trial)

dehydroepiandrosterone (2 trials)

dexamethasone (1 trial)

emtricitabine (emtriva) (1 trial)

entecavir (baraclude) (1 trial)

ginseng (1 trial)

huang qi gui zhi wu (1 trial)

interleukin-10 (1 trial)

iron sucrose (venofer) (1 trial)

kremezin (1 trial)

lactobacillus casei (1 trial)

lactobacillus rhamnosus (1 trial)

levofloxacin (levaquin) (4 trials)

l-glutamine (1 trial)

ligustrum vulgare pollen (1 trial)

pantoprazole (protonix) (3 trials)

remifentanil (ultiva) (1 trial)

rhodiola (1 trial)

rimabotulinumtoxinB (Myobloc) (1 trial)

soybean (1 trial)

tocotrienol (1 trial)

tumor necrosis factor (1 trial)

ubiquinone (1 trial)

uracil (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Adenocarcinoma (Phase 2)

Anterior Cruciate Ligament Injuries (Phase 4)

Arteriovenous Fistula (Phase 4)

Atrial Fibrillation (Phase 3)

Atrial Flutter (Phase 3)

Atrophy (Phase 3)

Back Pain (Phase 3)

Breast Neoplasms (Phase 2)

Carcinoma (Phase 4)

Carcinoma, Ductal (Phase 3)

Carcinoma, Ductal, Breast (Phase 3)

Carcinoma, Hepatocellular (Phase 4)

Carcinoma in Situ (Phase 3)

Carcinoma, Intraductal, Noninfiltrating (Phase 3)

Carcinoma, Squamous Cell (Phase 2)

Cerebral Infarction (Phase 4)

Cholangiocarcinoma (Phase 2)

Cicatrix (Phase 4)

Cicatrix, Hypertrophic (Phase 4)

Colorectal Neoplasms (Phase 4)

Communicable Diseases (Phase 4)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Major (Phase 4)

Diabetes Mellitus (Phase 2)

Diabetic Foot (Phase 2)

Diarrhea (Phase 4)

Endometrial Neoplasms (Phase 2)

Enteritis (Phase 4)

Fatigue (Phase 3)

Fatty Liver (Phase 2)

Fibrosis (Phase 4)

Foot Ulcer (Phase 2)

Gastroenteritis (Phase 4)

Gastroesophageal Reflux (Phase 4)

Gastrointestinal Hemorrhage (Phase 4)

Heart Failure (Phase 4)

Heart Failure, Systolic (Phase 4)

Helicobacter Infections (Phase 4)

Hemorrhage (Phase 4)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 4)

Hepatitis, Chronic (Phase 4)

Hodgkin Disease (Phase 2)

Hypertrophy (Phase 4)

Infections (Phase 4)

Insulin Resistance (Phase 3)

Intraabdominal Infections (Phase 4)

Ischemia (Phase 4)

Keloid (Phase 4)

Kidney Failure, Chronic (Phase 4)

Liver Cirrhosis (Phase 4)

Low Back Pain (Phase 3)

Lymphoma (Phase 2)

Lymphoma, B-Cell (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Macular Edema (Phase 3)

Mitral Valve Insufficiency (Phase 4)

Multiple Myeloma (Phase 2)

Muscular Atrophy (Phase 3)

Muscular Atrophy, Spinal (Phase 3)

Nasopharyngeal Carcinoma (Phase 3)

Neoplasm Metastasis (Phase 2)

Neoplasms (Phase 2)

Neoplasms, Plasma Cell (Phase 2)

Non-alcoholic Fatty Liver Disease (Phase 2)

Osteoarthritis (Phase 2)

Osteonecrosis (Phase 4)

Pain, Postoperative (Phase 4)

Pancreatic Neoplasms (Phase 2)

Peripheral Arterial Disease (Phase 4)

Peripheral Vascular Diseases (Phase 4)

Pneumonia (Phase 2)

Purpura (Phase 2)

Purpura, Thrombocytopenic (Phase 2)

Purpura, Thrombocytopenic, Idiopathic (Phase 2)

Radiodermatitis (Phase 2)

Rectal Neoplasms (Phase 2)

Recurrence (Phase 4)

Schizophrenia (Phase 4)

Sjogren's Syndrome (Phase 2)

Stroke (Phase 4)

Syndrome (Phase 2)

Thrombosis (Phase 3)

Ulcer (Phase 2)

Uterine Cervical Neoplasms (Phase 2)

Venous Thrombosis (Phase 3)

Virus Diseases (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 141
# of Trial APIs: 133